Graphical representation of incidence of infections. (A) Incidence of infections and of grade ≥3 infections in percent reported in studies with BsABs. (B) The incidence of infections normalized to a 1-month observation period per 100 patients. (C) The incidence of each infectious event per month in the MajesTEC-1 trial. (D) The incidence of each infectious event every 2-months period normalized to 100 patients in the MajesTEC-1 trial (data digitized from Nooka et al⁴).